Endorsement of alternative medicine and vaccine hesitancy among physicians: A cross-sectional study in four European countries

Hum Vaccin Immunother. 2023 Aug 1;19(2):2242748. doi: 10.1080/21645515.2023.2242748.

Abstract

Vaccine hesitancy has become a threat to public health, especially as it is a phenomenon that has also been observed among healthcare professionals. In this study, we analyzed the relationship between endorsement of complementary and alternative medicine (CAM) and vaccination attitudes and behaviors among healthcare professionals, using a cross-sectional sample of physicians with vaccination responsibilities from four European countries: Germany, Finland, Portugal, and France (total N = 2,787). Our results suggest that, in all the participating countries, CAM endorsement is associated with lower frequency of vaccine recommendation, lower self-vaccination rates, and being more open to patients delaying vaccination, with these relationships being mediated by distrust in vaccines. A latent profile analysis revealed that a profile characterized by higher-than-average CAM endorsement and lower-than-average confidence and recommendation of vaccines occurs, to some degree, among 19% of the total sample, although these percentages varied from one country to another: 23.72% in Germany, 17.83% in France, 9.77% in Finland, and 5.86% in Portugal. These results constitute a call to consider health care professionals' attitudes toward CAM as a factor that could hinder the implementation of immunization campaigns.

Keywords: Alternative medicine; CAM; evidence-based practice; physicians; vaccine hesitancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Complementary Therapies*
  • Cross-Sectional Studies
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Physicians*
  • Vaccination
  • Vaccination Hesitancy
  • Vaccines*

Substances

  • Vaccines

Grants and funding

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 964728 (JITSUVAX). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.